CLINICAL_TRIALS
trial_result
· 2017-10-05
Clinical Trial Update: PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate [Phase 2, Phase 3]
Summary
A Phase 2/3 trial investigated dose response effects of exogenous testosterone on the prostate in healthy volunteers; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Healthy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-10-05